---
title: "胰腺癌中肿瘤反应性与旁观者CD8+ T细胞克隆型分析"
date: 2025-04-08T03:04:44Z
draft: ["false"]
tags: [
  "fetched",
  "生信漫漫学"
]
categories: ["Acdemic"]
---
胰腺癌中肿瘤反应性与旁观者CD8+ T细胞克隆型分析 by 生信漫漫学
------
<div><section data-tool="mdnice编辑器" data-website="https://www.mdnice.com"><h2 data-cacheurl="" data-remoteid="" data-tool="mdnice编辑器"><span></span><span><span leaf="">文章概述</span></span><span></span></h2><p data-tool="mdnice编辑器"><strong><span leaf="">文章标题：</span></strong><span leaf="">《Transcriptome-based identification of tumor-reactive and bystander CD8 + T cell receptor clonotypes in human pancreatic cancer.》</span></p><p data-tool="mdnice编辑器"><strong><span leaf="">发表日期和杂志：</span></strong><span leaf="">2023年发表在Science Translational Medicine上</span></p><p data-tool="mdnice编辑器"><strong><span leaf="">在线阅读链接：</span></strong><span leaf="">https://doi.org/10.1126/scitranslmed.adh9562</span></p><h3 data-tool="mdnice编辑器"><span data-cacheurl="" data-remoteid=""></span><span></span><span><span leaf="">研究背景</span></span><span></span></h3><p data-tool="mdnice编辑器"><strong><span leaf="">1. PDAC对免疫检查点阻断疗法的耐药性</span></strong></p><ul><li><section><p><span leaf="">胰腺导管腺癌（PDAC）通常对免疫检查点阻断（ICB）疗法不敏感，大多数PDAC患者无法从当前的免疫治疗中获益。</span></p></section></li><li><section><p><span leaf="">这种癌症类型被归类为“免疫冷”肿瘤，即肿瘤微环境中缺乏足够的免疫细胞浸润或免疫激活。</span></p></section></li></ul><p data-tool="mdnice编辑器"><strong><span leaf="">2. 遗传不稳定的肿瘤可能受益</span></strong></p><ul><li><section><p><span leaf="">尽管PDAC整体对ICB耐药，但具有遗传不稳定的肿瘤（如错配修复缺陷，MMR-D）患者可能会从ICB中获得一定的疗效。</span></p></section></li><li><section><p><span leaf="">这种遗传不稳定性通常与更高的突变负荷相关，从而可能产生更多的肿瘤特异性抗原，激发免疫反应。</span></p></section></li></ul><p data-tool="mdnice编辑器"><strong><span leaf="">3. 肿瘤反应性CD8+ T细胞的存在</span></strong></p><ul><li><section><span leaf="">在PDAC样本中存在能够识别肿瘤细胞的CD8+ T细胞（即肿瘤反应性T细胞）。这些T细胞的存在表明PDAC中可能存在适应性免疫反应，尽管整体免疫治疗效果不佳。</span></section></li></ul><h3 data-tool="mdnice编辑器"><span data-cacheurl="" data-remoteid=""></span><span></span><span><span leaf="">数据详情</span></span><span></span></h3><p data-tool="mdnice编辑器"><strong><span leaf="">单细胞转录组学数据</span></strong><span leaf="">：对来自9个PDAC患者的肿瘤样本中的CD45+CD3+ T细胞进行了单细胞转录组测序。这些样本</span><strong><span leaf="">包括3个遗传不稳定的肿瘤样本和6个遗传稳定的肿瘤样本。</span></strong></p><p data-tool="mdnice编辑器"><strong><span leaf="">TCR功能测试</span></strong><span leaf="">：对</span><strong><span leaf="">从单细胞数据中鉴定出的TCR克隆型进行了功能测试</span></strong><span leaf="">，以评估这些T细胞是否能够识别并反应自体肿瘤细胞。这种测试通过检测T细胞在与肿瘤细胞共培养时的细胞因子分泌（如TNF-α）和细胞毒性标志物（如CD107a）来评估T细胞的活性。</span></p><p data-tool="mdnice编辑器"><strong><span leaf="">数据链接是</span></strong><span leaf="">：https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE254250</span></p><figure data-tool="mdnice编辑器"><span leaf=""><img data-imgfileid="100045049" data-ratio="0.2082139446036294" data-src="https://mmbiz.qpic.cn/mmbiz_png/siaia0BDGJdjQDzKFl68SpYk0ibfakn6pFkfHicWCibBqZNGaj26VneWfTRpAWbjF7U8eFkMSjRo7XksksSRdwJsHiaw/640?wx_fmt=png&amp;from=appmsg" data-type="png" data-w="1047" src="https://mmbiz.qpic.cn/mmbiz_png/siaia0BDGJdjQDzKFl68SpYk0ibfakn6pFkfHicWCibBqZNGaj26VneWfTRpAWbjF7U8eFkMSjRo7XksksSRdwJsHiaw/640?wx_fmt=png&amp;from=appmsg"></span></figure><p data-tool="mdnice编辑器"><strong><span leaf="">样品详情：</span></strong></p><pre data-tool="mdnice编辑器"><span data-cacheurl="" data-remoteid=""></span><code><span leaf="">GSM8036581 249_GEX</span><span leaf=""><br></span><span leaf="">GSM8036589 249_VDJ</span><span leaf=""><br></span><span leaf="">GSM8036595 262_GEX</span><span leaf=""><br></span><span leaf="">GSM8036602 262_VDJ</span><span leaf=""><br></span><span leaf="">GSM8036609 282_GEX</span><span leaf=""><br></span><span leaf="">GSM8036615 282_VDJ</span><span leaf=""><br></span><span leaf="">GSM8036623 309_GEX</span><span leaf=""><br></span><span leaf="">GSM8036629 418_GEX</span><span leaf=""><br></span><span leaf="">GSM8036630 418_VDJ</span><span leaf=""><br></span><span leaf="">GSM8036631 432_GEX</span><span leaf=""><br></span><span leaf="">GSM8036632 432_HASH</span><span leaf=""><br></span><span leaf="">GSM8036633 432_VDJ</span><span leaf=""><br></span><span leaf="">GSM8036634 Pool</span><span><span leaf="">#301/#413/#416_GEX</span></span><span leaf=""><br></span><span leaf="">GSM8036635 Pool</span><span><span leaf="">#301/#413/#416_HASH</span></span><span leaf=""><br></span><span leaf="">GSM8036636 Pool</span><span><span leaf="">#301/#413/#416_VDJ</span></span><span leaf=""><br></span><span leaf=""><br></span></code></pre><p data-tool="mdnice编辑器"><strong><span leaf="">样本特征</span></strong></p><ul><li><section><span leaf="">样本#249：因BRCA1基因的体细胞突变导致同源DNA修复缺陷。</span></section></li><li><section><span leaf="">样本#282：因PALB2基因的体细胞突变导致同源DNA修复缺陷，并表现出微卫星不稳定性（MSI）。</span></section></li><li><section><span leaf="">样本#309：来自一种间变性癌，该癌携带KMT2C基因（一种表观遗传调节因子）的突变。</span></section></li></ul><p data-tool="mdnice编辑器"><strong><span leaf="">这些肿瘤样本显示出更多的体细胞突变，增加了免疫原性T细胞新表位表达的可能性。</span></strong></p><figure data-tool="mdnice编辑器"><span leaf=""><img data-imgfileid="100045050" data-ratio="0.5202072538860104" data-src="https://mmbiz.qpic.cn/mmbiz_png/siaia0BDGJdjQDzKFl68SpYk0ibfakn6pFkw8VzSialiafN5wqJqvSl1iavMPZtqg4zoQhBB6lwH4iadpkGhe5GEcVL0Q/640?wx_fmt=png&amp;from=appmsg" data-type="png" data-w="965" src="https://mmbiz.qpic.cn/mmbiz_png/siaia0BDGJdjQDzKFl68SpYk0ibfakn6pFkw8VzSialiafN5wqJqvSl1iavMPZtqg4zoQhBB6lwH4iadpkGhe5GEcVL0Q/640?wx_fmt=png&amp;from=appmsg"></span></figure><p data-tool="mdnice编辑器"><strong><span leaf="">单细胞数据详情：</span></strong></p><pre data-tool="mdnice编辑器"><span data-cacheurl="" data-remoteid=""></span><code><span leaf="">GSE254250_249_GEX_filtered_feature_bc_matrix.h5 17.1 Mb </span><span leaf=""><br></span><span leaf="">GSE254250_262_GEX_filtered_feature_bc_matrix.h5 10.1 Mb </span><span leaf=""><br></span><span leaf="">GSE254250_282_GEX_filtered_feature_bc_matrix.h5 4.4 Mb </span><span leaf=""><br></span><span leaf="">GSE254250_309_GEX_filtered_feature_bc_matrix.h5 18.3 Mb </span><span leaf=""><br></span><span leaf="">GSE254250_418_GEX_filtered_feature_bc_matrix.h5 10.7 Mb </span><span leaf=""><br></span><span leaf="">GSE254250_432_GEX_filtered_feature_bc_matrix.h5 22.5 Mb </span><span leaf=""><br></span><span leaf="">GSE254250_PDAC_9sample_CD8_RNA_expression_matrix.csv.gz 201.8 Mb</span><span leaf=""><br></span><span leaf="">GSE254250_PDAC_9sample_CD8_RNA_metadata_matrix.csv.gz 338.1 Kb</span><span leaf=""><br></span><span leaf="">GSE254250_Pool_GEX_filtered_feature_bc_matrix.h5 31.5 Mb </span><span leaf=""><br></span></code></pre><p data-tool="mdnice编辑器"><span leaf="">提供的是</span><code><span leaf="">h5</span></code><span leaf="">格式的文本压缩文件，下载需要的文件之后，使用</span><code><span leaf="">Read10X_h5()</span></code><span leaf="">函数读取批量读取即可</span></p><h3 data-tool="mdnice编辑器"><span data-cacheurl="" data-remoteid=""></span><span></span><span><span leaf="">T细胞亚群分析</span></span><span></span></h3><p data-tool="mdnice编辑器"><span leaf="">对9个原发性胰腺癌切除肿瘤样本中的CD45+CD3+ T细胞进行了单细胞转录组测序,通过无监督聚类分析，</span><strong><span leaf="">T细胞被分为10个群体：4个CD8+亚群、5个CD4+亚群和1个增殖T细胞群体。</span></strong></p><figure data-tool="mdnice编辑器"><span leaf=""><img data-src="https://mmbiz.qpic.cn/mmbiz_png/siaia0BDGJdjQDzKFl68SpYk0ibfakn6pFkb1A2I4aPgvbHWv8tdVEzDYGObvqPskMicCMD81tztbozapa27nlDfqg/640?wx_fmt=png&amp;from=appmsg" data-ratio="0.9002242152466368" data-type="png" data-w="892" data-imgfileid="100045053" src="https://mmbiz.qpic.cn/mmbiz_png/siaia0BDGJdjQDzKFl68SpYk0ibfakn6pFkb1A2I4aPgvbHWv8tdVEzDYGObvqPskMicCMD81tztbozapa27nlDfqg/640?wx_fmt=png&amp;from=appmsg"></span></figure><p data-tool="mdnice编辑器"><span leaf="">顶部的三个UMAP图分别展示了</span><strong><span leaf="">CD8A（CD8α）：标记CD8+细胞毒性T细胞、CD4：标记CD4+辅助性T细胞和FOXP3：标记调节性T细胞（Tregs）的表达情况。</span></strong></p><figure data-tool="mdnice编辑器"><span leaf=""><img data-src="https://mmbiz.qpic.cn/mmbiz_png/siaia0BDGJdjQDzKFl68SpYk0ibfakn6pFkYmCia2sYwrafLSASw85VpFo7zqhbBvibialicfpm3sDCEdnd6ug0FjuI5Q/640?wx_fmt=png&amp;from=appmsg" data-ratio="2.0146252285191957" data-type="png" data-w="547" data-imgfileid="100045051" src="https://mmbiz.qpic.cn/mmbiz_png/siaia0BDGJdjQDzKFl68SpYk0ibfakn6pFkYmCia2sYwrafLSASw85VpFo7zqhbBvibialicfpm3sDCEdnd6ug0FjuI5Q/640?wx_fmt=png&amp;from=appmsg"></span></figure><p data-tool="mdnice编辑器"><strong><span leaf="">克隆型分布：</span></strong><span leaf="">底部的UMAP图展示了</span><strong><span leaf="">基于单细胞TCR测序（scTCR-seq）数据的最扩增克隆型的位置</span></strong><span leaf="">，有助于理解哪些T细胞克隆型在肿瘤中最为丰富。</span></p><figure data-tool="mdnice编辑器"><span leaf=""><img data-src="https://mmbiz.qpic.cn/mmbiz_png/siaia0BDGJdjQDzKFl68SpYk0ibfakn6pFkbJA9zlvvkoDnFW4Q9Jedzxic0JdiaQpl3qsCdNxxBU6FLBrfcGZ9jlicw/640?wx_fmt=png&amp;from=appmsg" data-ratio="0.83399209486166" data-type="png" data-w="506" data-imgfileid="100045052" src="https://mmbiz.qpic.cn/mmbiz_png/siaia0BDGJdjQDzKFl68SpYk0ibfakn6pFkbJA9zlvvkoDnFW4Q9Jedzxic0JdiaQpl3qsCdNxxBU6FLBrfcGZ9jlicw/640?wx_fmt=png&amp;from=appmsg"></span></figure><p data-tool="mdnice编辑器"><strong><span leaf="">关键T细胞亚群特征基因：</span></strong></p><figure data-tool="mdnice编辑器"><span leaf=""><img data-src="https://mmbiz.qpic.cn/mmbiz_png/siaia0BDGJdjQDzKFl68SpYk0ibfakn6pFkic66oM6qZAarT9SPAEHwias6PW2XyCaSmNOZsLTHgbjnqyZdLxHQUoWQ/640?wx_fmt=png&amp;from=appmsg" data-ratio="0.4148148148148148" data-type="png" data-w="1080" data-imgfileid="100045058" src="https://mmbiz.qpic.cn/mmbiz_png/siaia0BDGJdjQDzKFl68SpYk0ibfakn6pFkic66oM6qZAarT9SPAEHwias6PW2XyCaSmNOZsLTHgbjnqyZdLxHQUoWQ/640?wx_fmt=png&amp;from=appmsg"></span></figure><ul><li><section><span leaf="">耗竭CD8+ T细胞簇：表达PD-1、TIM3、LAG3、CTLA-4和TIGIT等耗竭标志物，以及PRF1（穿孔素）、GNLY（颗粒酶）等效应标志物。该簇进一步分为耗竭（Tex）和预耗竭（Tpex）两个亚群。</span></section></li><li><section><span leaf="">增殖T细胞簇（Tprolif）：除了上述标志物外，还表达与细胞分裂相关的MKI67。</span></section></li><li><section><span leaf="">CD4+ Treg细胞簇：表达FOXP3和IL2RA，同时高表达OX40、4-1BB和GITR等TNFRSF成员，以及CTLA-4和TIGIT。</span></section></li><li><section><span leaf="">耗竭CD4+ T细胞簇：表达与耗竭相关的基因标志物，但缺乏FOXP3和IL2RA表达，高表达CXCL13。</span></section></li></ul><h3 data-tool="mdnice编辑器"><span data-cacheurl="" data-remoteid=""></span><span></span><span><span leaf="">肿瘤反应性T细胞受体（TCR）鉴定</span></span><span></span></h3><p data-tool="mdnice编辑器"><strong><span leaf="">鉴定肿瘤反应性TCR克隆型</span></strong><span leaf="">：通过系统性功能测试，从单细胞转录组数据中鉴定能够识别自体肿瘤细胞的肿瘤反应性（TR）T细胞克隆型。</span></p><figure data-tool="mdnice编辑器"><span leaf=""><img data-src="https://mmbiz.qpic.cn/mmbiz_png/siaia0BDGJdjQDzKFl68SpYk0ibfakn6pFkrltR5rsUibjp95uvRQObtXPtAMkzvmoatgal7EHxWYQFx4VGSe1Dqbw/640?wx_fmt=png&amp;from=appmsg" data-ratio="0.38333333333333336" data-type="png" data-w="1080" data-imgfileid="100045056" src="https://mmbiz.qpic.cn/mmbiz_png/siaia0BDGJdjQDzKFl68SpYk0ibfakn6pFkrltR5rsUibjp95uvRQObtXPtAMkzvmoatgal7EHxWYQFx4VGSe1Dqbw/640?wx_fmt=png&amp;from=appmsg"></span></figure><p data-tool="mdnice编辑器"><span leaf="">从单细胞转录组数据集中提取TCRαβ配对信息，用于功能测试。由于PDAC样本中体细胞突变数量较少，选择对自体肿瘤细胞进行无偏筛选，而不是基于预测的突变编码新表位进行筛选。</span></p><p data-tool="mdnice编辑器"><strong><span leaf="">选择CD8+ T细胞亚群</span></strong></p><figure data-tool="mdnice编辑器"><span leaf=""><img data-src="https://mmbiz.qpic.cn/mmbiz_png/siaia0BDGJdjQDzKFl68SpYk0ibfakn6pFkaicYLnGvMjzEFibs3Ivh3JjibwpiaHzGhH795bg1g9OTq8vRUvdFJlZ0MA/640?wx_fmt=png&amp;from=appmsg" data-ratio="0.7972972972972973" data-type="png" data-w="444" data-imgfileid="100045055" src="https://mmbiz.qpic.cn/mmbiz_png/siaia0BDGJdjQDzKFl68SpYk0ibfakn6pFkaicYLnGvMjzEFibs3Ivh3JjibwpiaHzGhH795bg1g9OTq8vRUvdFJlZ0MA/640?wx_fmt=png&amp;from=appmsg"></span></figure><p data-tool="mdnice编辑器"><span leaf="">研究专注于CD8+ T细胞亚群，因为这些细胞中存在大量扩增的TCR克隆型，并且之前的研究已经发现了PDAC肿瘤浸润性淋巴细胞（TIL）培养物中的人类白细胞抗原（HLA）I类限制的肿瘤反应性T细胞。</span></p><p data-tool="mdnice编辑器"><strong><span leaf="">样本#309的分析</span></strong></p><ul><li><section><span leaf="">选择样本#309进行初步分析，因为它具有最高的T细胞数量和最高的CD8+:CD4+ T细胞比例。</span></section></li><li><section><span leaf="">该样本的CD8+ T细胞景观中存在明显的耗竭（Tex）、预耗竭（Tpex）和增殖（Tprolif）表型簇。</span></section></li></ul><figure data-tool="mdnice编辑器"><span leaf=""><img data-src="https://mmbiz.qpic.cn/mmbiz_png/siaia0BDGJdjQDzKFl68SpYk0ibfakn6pFkPOLVuHqhRsHznKr5EfjsrrJRn8GibwcBtT1e95YdgFFqSHicFUvU9Pfg/640?wx_fmt=png&amp;from=appmsg" data-ratio="0.3435185185185185" data-type="png" data-w="1080" data-imgfileid="100045057" src="https://mmbiz.qpic.cn/mmbiz_png/siaia0BDGJdjQDzKFl68SpYk0ibfakn6pFkPOLVuHqhRsHznKr5EfjsrrJRn8GibwcBtT1e95YdgFFqSHicFUvU9Pfg/640?wx_fmt=png&amp;from=appmsg"></span></figure><p data-tool="mdnice编辑器"><strong><span leaf="">鉴定肿瘤反应性TCR</span></strong></p><ul><li><section><span leaf="">针对样本#309中鉴定出的12个最扩增的T细胞克隆型进行初步功能测试。</span></section></li></ul><figure data-tool="mdnice编辑器"><span leaf=""><img data-src="https://mmbiz.qpic.cn/mmbiz_png/siaia0BDGJdjQDzKFl68SpYk0ibfakn6pFkV0KujjVj903A1icphbCg8SM1hZjZg5aoibqfho5bjXZPTR0oL4kjW2QA/640?wx_fmt=png&amp;from=appmsg" data-ratio="0.7621861152141802" data-type="png" data-w="677" data-imgfileid="100045054" src="https://mmbiz.qpic.cn/mmbiz_png/siaia0BDGJdjQDzKFl68SpYk0ibfakn6pFkV0KujjVj903A1icphbCg8SM1hZjZg5aoibqfho5bjXZPTR0oL4kjW2QA/640?wx_fmt=png&amp;from=appmsg"></span></figure><ul><li><section><span leaf="">通过体外转录的mRNA将相应的TCRαβ配对瞬时转染到主要由CD8+ T细胞组成的人类T细胞系（T222）中。</span></section></li><li><section><span leaf="">与样本#309衍生的肿瘤细胞共培养5小时后，通过流式细胞术检测肿瘤坏死因子-α（TNF-α）和CD107a的表达，以评估T细胞的效应功能（细胞因子产生和细胞毒性）。</span></section></li></ul><figure data-tool="mdnice编辑器"><span leaf=""><img data-src="https://mmbiz.qpic.cn/mmbiz_png/siaia0BDGJdjQDzKFl68SpYk0ibfakn6pFkYvQTqYKnCfvK2nKOY7Sicvqp0Atm1DLBE4K67o2RnGlk2TVNQoDMyBA/640?wx_fmt=png&amp;from=appmsg" data-ratio="0.5602294455066922" data-type="png" data-w="1046" data-imgfileid="100045063" src="https://mmbiz.qpic.cn/mmbiz_png/siaia0BDGJdjQDzKFl68SpYk0ibfakn6pFkYvQTqYKnCfvK2nKOY7Sicvqp0Atm1DLBE4K67o2RnGlk2TVNQoDMyBA/640?wx_fmt=png&amp;from=appmsg"></span></figure><ul><li><section><span leaf="">使用小鼠TCRβ恒定域特异性抗体检测目标TCR，减少与内源性人类TCR链的错误配对。</span></section></li><li><section><span leaf="">在测试的12个TCR中，有7个介导了对#309肿瘤细胞的T细胞反应性。</span></section></li><li><section><span leaf="">这些TCR的反应性强度不同，可能是由于肿瘤细胞上抗原识别的差异。</span></section></li></ul><p data-tool="mdnice编辑器"><strong><span leaf="">UMAP分析</span></strong></p><ul><li><section><span leaf="">将功能测试结果映射到UMAP图上，发现属于7个肿瘤反应性克隆型的T细胞主要位于Tex、Tpex和Tprolif簇中，而5个非肿瘤反应性（NTR）克隆型的T细胞主要位于效应记忆（TEM2）和中央记忆（TCM）簇中。</span></section></li></ul><figure data-tool="mdnice编辑器"><span leaf=""><img data-src="https://mmbiz.qpic.cn/mmbiz_png/siaia0BDGJdjQDzKFl68SpYk0ibfakn6pFkmsXC2sjBe17fOqLVMaiaRCvxJX3KQjl7uaenWfWznjEeOFbkXUYMmkw/640?wx_fmt=png&amp;from=appmsg" data-ratio="0.7814207650273224" data-type="png" data-w="732" data-imgfileid="100045061" src="https://mmbiz.qpic.cn/mmbiz_png/siaia0BDGJdjQDzKFl68SpYk0ibfakn6pFkmsXC2sjBe17fOqLVMaiaRCvxJX3KQjl7uaenWfWznjEeOFbkXUYMmkw/640?wx_fmt=png&amp;from=appmsg"></span></figure><ul><li><section><span leaf="">基于这种分布，进一步选择了22个TCR克隆型进行测试，最终鉴定出21个肿瘤反应性TCR和13个非肿瘤反应性TCR。</span></section></li></ul><figure data-tool="mdnice编辑器"><span leaf=""><img data-src="https://mmbiz.qpic.cn/mmbiz_png/siaia0BDGJdjQDzKFl68SpYk0ibfakn6pFkWQMiaQYWPOedtWJqhticatmdA2QwT2vlCT7c2RcnR7tREJHjbVOOmt7A/640?wx_fmt=png&amp;from=appmsg" data-ratio="0.43029739776951675" data-type="png" data-w="1076" data-imgfileid="100045060" src="https://mmbiz.qpic.cn/mmbiz_png/siaia0BDGJdjQDzKFl68SpYk0ibfakn6pFkWQMiaQYWPOedtWJqhticatmdA2QwT2vlCT7c2RcnR7tREJHjbVOOmt7A/640?wx_fmt=png&amp;from=appmsg"></span></figure><p data-tool="mdnice编辑器"><strong><span leaf="">IFN-γ预处理的影响</span></strong></p><ul><li><section><span leaf="">对于大多数肿瘤反应性TCR，当肿瘤细胞经过IFN-γ预处理时，T细胞的反应性增强。</span></section></li><li><section><span leaf="">IFN-γ预处理增加了肿瘤细胞表面的HLA I类表达，并增强了抗原加工。</span></section></li></ul><p data-tool="mdnice编辑器"><strong><span leaf="">TCR CT4的特殊性</span></strong></p><figure data-tool="mdnice编辑器"><span leaf=""><img data-src="https://mmbiz.qpic.cn/mmbiz_png/siaia0BDGJdjQDzKFl68SpYk0ibfakn6pFktsBslxWoAI1b6MzLGTRskaJxlz0lXeiaZGIvTPpNoFia4tdBe1qeaNVw/640?wx_fmt=png&amp;from=appmsg" data-ratio="0.5685522531160115" data-type="png" data-w="1043" data-imgfileid="100045062" src="https://mmbiz.qpic.cn/mmbiz_png/siaia0BDGJdjQDzKFl68SpYk0ibfakn6pFktsBslxWoAI1b6MzLGTRskaJxlz0lXeiaZGIvTPpNoFia4tdBe1qeaNVw/640?wx_fmt=png&amp;from=appmsg"></span></figure><ul><li><section><span leaf="">TCR CT4在初始实验中显示出对肿瘤细胞的反应性，但在后续测试中未能介导T细胞反应性，尽管它对新鲜分离的患者来源异种移植（PDX）细胞悬液表现出反应性。</span></section></li><li><section><span leaf="">进一步测试表明，这种差异与#309肿瘤细胞系的不同亚培养有关，这些亚培养之间存在显著的异质性。</span></section></li></ul><h3 data-tool="mdnice编辑器"><span data-cacheurl="" data-remoteid=""></span><span></span><span><span leaf="">文末友情宣传</span></span><span></span></h3><p data-tool="mdnice编辑器"><a href="https://mp.weixin.qq.com/s?__biz=MzAxMDkxODM1Ng==&amp;mid=2247539788&amp;idx=1&amp;sn=62a09c7af6373658bf81c149eb0b4026&amp;scene=21#wechat_redirect"><span leaf="">生信入门&amp;数据挖掘线上直播课4月班</span></a></p><p data-tool="mdnice编辑器"><a href="https://mp.weixin.qq.com/s?__biz=MzAxMDkxODM1Ng==&amp;mid=2247524148&amp;idx=1&amp;sn=7806da6feb41a36493c519c1cfc1d3ac&amp;scene=21#wechat_redirect"><span leaf="">时隔5年，我们的生信技能树VIP学徒继续招生啦</span></a></p><p data-tool="mdnice编辑器"><a href="https://mp.weixin.qq.com/s?__biz=MzAxMDkxODM1Ng==&amp;mid=2247535760&amp;idx=2&amp;sn=1e02a2e982a046ecf6389231e6768d5b&amp;scene=21#wechat_redirect"><span leaf="">满足你生信分析计算需求的低价解决方案</span></a></p></section><section><span leaf=""><br></span></section><p><mp-style-type data-value="3"></mp-style-type></p></div>  
<hr>
<a href="https://mp.weixin.qq.com/s/UVyUUPsyRxwhx0kHFPF16w",target="_blank" rel="noopener noreferrer">原文链接</a>
